Investments Press Releases

02.29.2024

Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth

12.14.2023

Pfizer Completes Acquisition of Seagen

12.12.2023

Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen

03.13.2023

Pfizer Invests $43 Billion to Battle Cancer

10.05.2022

Pfizer Completes Acquisition of Global Blood Therapeutics 

10.03.2022

Pfizer Completes Acquisition of Biohaven Pharmaceuticals

08.08.2022

Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology

06.28.2022

Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus

06.23.2022

Valneva and Pfizer Announce Closing of Equity Investment

06.09.2022

Pfizer Completes Acquisition of ReViral

06.06.2022

Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.

06.01.2022

Pfizer Provides Update on Ownership Interest in Haleon